purpose phase study carbon ion radiotherapy stage lung cancer nsclc conducted NUMBER NUMBER determined optimal dose second phase ii study using optimal dose performed purpose present study clarify local control survival rates methods materials april NUMBER december NUMBER NUMBER patients NUMBER primary lesions treated using fixed dose NUMBER gye fractions NUMBER weeks primary tumors irradiated carbon ion beams average age patients NUMBER years NUMBER medically inoperable local control survival determined using method data statistically processed using test results patients observed minimum NUMBER years death median time NUMBER months range months local control rate patients NUMBER patients causespecific survival rate NUMBER ia NUMBER ib NUMBER overall survival NUMBER ia NUMBER ib NUMBER toxic reactions lung greater grade NUMBER detected conclusions carbon ion radiotherapy new treatment modality superior benefits terms quality life activity daily living proven valid alternative surgery stage nsclc offer particular benefits especially elderly inoperable patients non small cell NUMBER year thirty kaplan meier log rank follow NUMBER NUMBER NUMBER year ii